Skip to main content
. Author manuscript; available in PMC: 2023 Apr 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2022 Apr 1;89(4):405–413. doi: 10.1097/QAI.0000000000002892

Figure 1. Visual of two participant case studies of IRR.

Figure 1.

A) Participant A, who developed urticaria after the first infusion. B) Participant B, who developed dyspnea with rash after the fifth infusion.